BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29510916)

  • 1. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
    Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
    Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
    Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
    Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.
    Borrego B; Argilaguet JM; Pérez-Martín E; Dominguez J; Pérez-Filgueira M; Escribano JM; Sobrino F; Rodriguez F
    Antiviral Res; 2011 Nov; 92(2):359-63. PubMed ID: 21820470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
    Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
    Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in Japan.
    Fukai K; Nishi T; Shimada N; Morioka K; Yamada M; Yoshida K; Sakamoto K; Kitano R; Yamazoe R; Yamakawa M
    J Vet Med Sci; 2017 Jan; 79(1):128-136. PubMed ID: 27773883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
    Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
    Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
    Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH
    J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.